Gara Jalqabaatti › Baayyee Ulfaataa › Florida › Orlando
Qorannoo klinikaalii Baayyee Ulfaataa Orlando, FL keessatti
Qorannoo 27 Baayyee Ulfaataa f Orlando fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Namoota walitti qabaa jiraSadarkaa 3
- Clinical Neuroscience Solutions - Orlando, Orlando
- Combined Research Orlando Phase I IV, Orlando
- Florida Institute for Clinical Research, Orlando
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Namoota walitti qabaa jiraSadarkaa 3
- Florida Institute for Clinical Research, Orlando
- Conquest Research - Winter Park, Winter Park · Miili 5 fagaatti
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Namoota walitti qabaa jiraSadarkaa 3
- West Orange Endocrinology, Ocoee · Miili 10 fagaatti
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Namoota walitti qabaa jiraSadarkaa 2
- Charter Research - Winter Park /ID# 281968, Orlando
- Florida Institute For Clinical Research /ID# 282739, Orlando
Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
Namoota walitti qabaa jira
- Orlando Health, Inc., Orlando
A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
- Kailera Clinical Site, Orlando
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Namoota walitti qabaa jiraSadarkaa 3
- Florida Institute for Clinical Research, LLC, Orlando
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Namoota walitti qabaa jiraSadarkaa 2
- Clinical Site Partners, LLC DBA Flourish Research, Winter Park · Miili 5 fagaatti
- K2 Medical Research Maitland LLC, Main Office, Maitland · Miili 6 fagaatti
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Namoota walitti qabaa jiraSadarkaa 2
- Clinical Neuroscience Solutions, Orlando
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Headlands Research Orlando, Orlando
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Namoota walitti qabaa jiraSadarkaa 3
- Florida Inst For Clin Res LLC, Orlando
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Namoota walitti qabaa jiraSadarkaa 3
- Clinical Neuroscience Solution, Orlando
- Florida Institute for Clinical Research, LLC, Orlando
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Namoota walitti qabaa jiraSadarkaa 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Namoota walitti qabaa jiraSadarkaa 3
- Florida Hospital- Center for Pediatric Research, Orlando
- Nemours Children's Health, Orlando
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Namoota walitti qabaa jiraSadarkaa 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- Clinical Site Partners, LLC dba Flourish Research, Winter Park · Miili 5 fagaatti
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Namoota walitti qabaa jiraSadarkaa 3
- Conquest Research, Winter Park · Miili 5 fagaatti
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Namoota walitti qabaa jiraSadarkaa 2
- Charter Research - Winter Park, Orlando
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Ocoee · Miili 10 fagaatti
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- AURORA-2 Clinical Site, Winter Park · Miili 5 fagaatti
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Namoota walitti qabaa jiraSadarkaa 3
- AURORA-1 Clinical Site, Winter Park · Miili 5 fagaatti
Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households
Namoota walitti qabaa jira
- University of Central Florida, Orlando
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Namoota walitti qabaa jiraSadarkaa 3Hojjettoota fayyaa simatamoo
- ACCOMPLISH-2 Research Site, Ocoee · Miili 10 fagaatti
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Namoota walitti qabaa jiraSadarkaa 2
- Charter Research - Winter Park, Orlando
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Namoota walitti qabaa jiraSadarkaa 3
- Kailera Clinical Site, Orlando
- Kailera Clinical Site, Orlando
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Namoota walitti qabaa jiraSadarkaa 3
- Clinical Neuroscience Solutions, Orlando
- Florida Institute for Clinical Research, Orlando
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Namoota walitti qabaa jiraSadarkaa 3
- ACCOMPLISH-1 Research Site, Ocoee · Miili 10 fagaatti
Qorannoo Baayyee Ulfaataa magaalota biroo keessatti
- San Antonio, TXQorannoo 34
- Houston, TXQorannoo 33
- Chicago, ILQorannoo 29
- Las Vegas, NVQorannoo 23
- Miami, FLQorannoo 23
- Dallas, TXQorannoo 20
- Atlanta, GAQorannoo 20
- New York City, NYQorannoo 19
- Jacksonville, FLQorannoo 19
- Washington, DCQorannoo 19
- Austin, TXQorannoo 18
- Baltimore, MDQorannoo 18
Qorannoo biroo Orlando keessatti
- Kansara Qara'a Non-Small CellQorannoo 44
- ObesityQorannoo 32
- Kansara MetastatikiiQorannoo 29
- Dhukkubaa AlzheimerQorannoo 25
- Sukkaraa Gosa 2Qorannoo 25
- Saree (Gosoota Hunda)Qorannoo 24
- Saree OljooQorannoo 23
- Kansarii OvariiQorannoo 22
- Colitis UlcerativeQorannoo 22
- Dhibee QaraQorannoo 21
- Kansarii ColorectalQorannoo 19
- Dhibee Gaddii GuddaaQorannoo 19
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.